Clinical Roundup Phase I/Ib study shows novel immunotherapy delivery approach safe and beneficial for some melanoma patients with leptomeningeal disease March 31, 2023Vol.49 No.13
Clinical Roundup Study reveals link between major discrimination and frailty in African American cancer survivors March 24, 2023Vol.49 No.12
Clinical Roundup Sylvester investigators find disparities in mesothelioma survival due to social determinants, limited access March 24, 2023Vol.49 No.12
Clinical Roundup Sylvester researchers identify neutrophils as major factor in treatment resistance of pancreatic cancer March 24, 2023Vol.49 No.12
Clinical Roundup USC study on mutation linked to leukemia could lead to a way to identify patients most at risk March 24, 2023Vol.49 No.12
Clinical Roundup Yale physicians using new technology to diagnose lung cancer March 24, 2023Vol.49 No.12
Clinical Roundup COVID-19 vaccination rates lower in cancer patients with comorbidities, some cancer types, and social factors March 17, 2023Vol.49 No.11
Clinical Roundup Galera presents supplemental analysis of phase III ROMAN trial at ECHNO March 17, 2023Vol.49 No.11
Clinical Roundup NEOSTAR phase II platform trial demonstrates neoadjuvant immunotherapy can enhance response in operable NSCLC March 17, 2023Vol.49 No.11
Clinical Roundup Study finds a cause of resistance to revumenib in acute leukemia March 17, 2023Vol.49 No.11
